The drug in question goes beyond addressing GLP-1, with an effect closer to that of Wegovy
Cloudiness indicates either bacterial contamination or that the peptide has begun to degrade and precipitate out of solution
This creates the core investment question: Is it deep value or a falling knife/value trap? Ratios suggest deep value, with a forward earnings yield of ~12%, a dividend yield near 7%, and a Price-to-Book ratio near 1, implying pessimism is already priced in
Today, everyone is looking for the glow on their skin
For a patient starting at 155/95 mmHg, that combined effect could bring readings into the 130 to 140 range, which aligns with 2017 ACC/AHA hypertension guideline targets [6]
It is anti aging, anti wrinkles, pro nourish, and is a ready moisturizer any time